Caris Life Sciences, Inc. (CAI)
27.07
+0.94
(+3.60%)
USD |
NASDAQ |
Aug 25, 11:19
Caris Life Sciences Net Income (Quarterly) : -0.637M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.637M |
| March 31, 2026 | -0.51M |
| December 31, 2025 | 81.96M |
| September 30, 2025 | 24.32M |
| June 30, 2025 | -71.79M |
| Date | Value |
|---|---|
| March 31, 2025 | -102.58M |
| December 31, 2024 | -36.95M |
| September 30, 2024 | -67.73M |
| June 30, 2024 | -66.19M |
| March 31, 2024 | -111.03M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| CareDx, Inc. | 110.64M |
| Myriad Genetics, Inc. | -43.20M |
| BioRestorative Therapies, Inc. | -2.154M |
| Natera, Inc. | -66.97M |
| Exagen, Inc. | -3.196M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 263.71M |
| Total Expenses (Quarterly) | 264.35M |
| EPS Diluted (Quarterly) | -0.0022 |
| Enterprise Value | 7.043B |
| Gross Profit Margin (Quarterly) | 68.10% |
| Profit Margin (Quarterly) | -0.24% |
| Earnings Yield | 1.38% |
| Operating Earnings Yield | 2.00% |
| Normalized Earnings Yield | 1.643 |